logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
1/12/2020 7:37:36 PM Neurocrine Biosciences Reports NGREZZA Preliminary 2019 Net Product Sales Of About $753 Mln
1/10/2020 1:01:53 AM Neurocrine And Idorsia Amend Option Deal To License Novel Treatment For Rare Pediatric Epilepsy
12/2/2019 7:33:15 AM Neurocrine Biosciences, Xenon Pharma Announce License Agreement To Develop First-in-class Treatments For Epilepsy
11/4/2019 4:03:08 PM Neurocrine Biosciences Q3 EPS $0.56 Vs. $0.52 Year Ago
9/30/2019 4:02:01 PM Neurocrine Biosciences Appoints David Boyer As Chief Corporate Affairs Officer
9/11/2019 4:02:43 PM Neurocrine Biosciences Appoints Leslie Norwalk To Board Of Directors
8/5/2019 8:32:20 AM AbbVie Submits NDA For Elagolix For Management Of Heavy Menstrual Bleeding Associated With Uterine Fibroids In Women
7/29/2019 4:05:07 PM Neurocrine Biosciences Q2 EPS $0.54 Vs. Loss $0.07 Year Ago
5/20/2019 8:05:34 AM Neurocrine Biosciences Presents New Data From RE-KINECT
5/5/2019 10:30:23 AM Neurocrine And Voyager Therapeutics Announce Phase I Results For VY-AADC In Patients With Parkinson's Disease
  
 
>